Looking forward to sharing our poster later today examining the characteristics of ETV6 mutated myeloid neoplasms at #ASH22. Special thanks to Aref Al-Kali Chekkaf ismahene Mayo Clinic Comprehensive Cancer Center

Putting on University of Galway colours for today to share our poster (4603) on TRAIL engineered NK cells with enhanced innate anti-leukemic activity in #AML, at #ASH2022 Michael O'Dwyer Eva Szegezdi MargaretTwohig Eimear O'Reilly ONK Therapeutics ICAT Programme Cancer | University of Galway-HSE West North West

Clinical and Molecular Spectrum and Prognostic Outcomes of U2AF1 Mutan... sciencedirect.com/science/articl… #U2AF1 #Telomeres #Maladaptive #CHIP Alex Ferrer Talha Badar Aref Al-Kali Abhishek Mangaonkar Team Telomere Mayo Clinic Center for Individualized Medicine Stephanie Pritzl

Our paper by ⁦Mark Gurney⁩ on mutated #ETV6 myeloid neoplasms. Should it be one of the secondary mutations? #MDSsm #AMLsm #NGS The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms - Gurney - British Journal of Haematology onlinelibrary.wiley.com/doi/10.1111/bj…

Our myeloid fellowship is open! This is a 1-year clinical + research program where heme/onc fellows gain additional experience in AML, chronic myeloid disorders, and bone marrow failure syndromes. ECFMG certification required. Visa support is provided. bit.ly/3qvX2cJ

Congratulations to Dr. Eibhlin Higgins! After completing ID fellowship in Ireland, she was recruited for the subspecialty Ortho-ID (2022) and Transplant-ID (2023) fellowships at the Mayo Clinic. She will serve as ID consultant at the University Hospital Galway, Ireland.

#TP53 allelic status and CN-LOH in #CMML -Infrequent but relevant. Isochromosome 17q with monocytosis associated with poor outcomes Mark Gurney Mayo Clinic Comprehensive Cancer Center Eric Padron MD Moffitt Cancer Center Terra Lasho, PhD rdcu.be/dgnPD

Mpox in solid organ transplant recipients: multicenter case series Mostly kidney recipients. Many with HIV infection. High number of skin lesions. All treated with tecovirimat. One patient died; all others resolved by day 30. American Journal of Transplantation doi.org/10.1016/j.ajt.…

Abstract submission is open until 25th August. Looking forward to another meeting with high quality contents.

TET2 somatic copy number alterations and allelic imbalances in #CMML. sciencedirect.com/science/articl… #4q24 #CNLOH #endoreduplication #TET2 Mark Gurney Patricia T Greipp Mayo Clinic Comprehensive Cancer Center

Huge thank you to Michael O'Dwyer ICAT Programme Ollscoil na Gaillimhe | University of Galway Clair Gardiner for the opportunity and support and examiners UllrichLab Aideen Ryan for the engaging viva examination!

#BCOR impact in #MN by our group ⁦Haematologica⁩ ⭐️⬇️ TP53 ⭐️⬆️ U2AF1 RUNX1 ⭐️⬇️ OS regardless of dz ⭐️ HCT ⬆️ OS unless RUNX1+ ⁦Mayo Clinic Comprehensive Cancer Center⁩ Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms pubmed.ncbi.nlm.nih.gov/38299584/

jamanetwork.com/journals/jamao… Thanks to all involved in our study of baseline factors which associated with subsequent myeloid neoplasms in adult CAR-T recipients. Intuitively, age ≥65 and baseline thrombocytopenia <140 defined the highest risk group in this Mayo Clinic cohort.